EDITAS MEDICINE INC.
3.2150
07-11月-24 14:27:57
15 分の遅延
株式
-0.0650
-1.98%
本日の幅
3.1100 - 3.3000
ISIN
N/A
ソース
NASDAQ
-
07 10 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Editas Medicine to Present at Chardan’s 5th Annual Genetic Medicines Conference
30 9 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
29 9 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
Editas Medicine Names Emma Reeve to Board of Directors
08 9 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
Editas Medicine to Participate in Upcoming Investor Conferences
02 9 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
20 8 2021 15:20:00 提供 Nasdaq GlobeNewswire
-
Editas Medicine Announces Second Quarter 2021 Results and Business Updates
04 8 2021 06:00:01 提供 Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing Second Quarter 2021 Results and Corporate Update
28 7 2021 06:00:01 提供 Nasdaq GlobeNewswire
-
Editas Medicine Names Bruce E. Eaton, Ph.D., as Executive Vice President and Chief Business Officer
26 7 2021 08:00:00 提供 Nasdaq GlobeNewswire
-
23 6 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
15 6 2021 15:01:00 提供 Nasdaq GlobeNewswire
-
14 6 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
Editas Medicine Announces First Quarter 2021 Results and Update
05 5 2021 06:00:01 提供 Nasdaq GlobeNewswire
-
Editas Medicine Names Mark S. Shearman, Ph.D., as Chief Scientific Officer
05 5 2021 05:59:00 提供 Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing First Quarter 2021 Results and Corporate Update
28 4 2021 06:01:00 提供 Nasdaq GlobeNewswire